Quax PH - Search Results

1

Tumor necrosis factor-alpha plays an important role in restenosis development.

Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: quax ph. FASEB J. 2005 Dec;19(14):1998-2004. doi: 10.1096/fj.05-4634com. FASEB J. 2005. PMID: 16319143

2

Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

Lardenoye JH, Delsing DJ, de Vries MR, Deckers MM, Princen HM, Havekes LM, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Among authors: quax ph. Circ Res. 2000 Aug 4;87(3):248-53. doi: 10.1161/01.res.87.3.248. Circ Res. 2000. PMID: 10926877

3

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW. Quax PH, et al. Circulation. 2001 Jan 30;103(4):562-9. doi: 10.1161/01.cir.103.4.562. Circulation. 2001. PMID: 11157723

4

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: quax ph. Gene Ther. 2001 Apr;8(7):534-41. doi: 10.1038/sj.gt.3301437. Gene Ther. 2001. PMID: 11319620

5

VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area.

Tacken PJ, Delsing DJ, Gijbels MJ, Quax PH, Havekes LM, Hofker MH, van Dijk KW. Tacken PJ, et al. Among authors: quax ph. Atherosclerosis. 2002 May;162(1):103-10. doi: 10.1016/s0021-9150(01)00697-9. Atherosclerosis. 2002. PMID: 11947903

6

Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.

Engelse MA, Lardenoye JH, Neele JM, Grimbergen JM, De Vries MR, Lamfers ML, Pannekoek H, Quax PH, De Vries CJ. Engelse MA, et al. Among authors: quax ph. Circ Res. 2002 May 31;90(10):1128-34. doi: 10.1161/01.res.0000021044.53156.f5. Circ Res. 2002. PMID: 12039804

7

Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.

Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Among authors: quax ph. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1433-8. doi: 10.1161/01.atv.0000030339.79524.6e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12231562

8

Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice.

Lardenoye JH, de Vries MR, Löwik CW, Xu Q, Dhore CR, Cleutjens JP, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Among authors: quax ph. Circ Res. 2002 Oct 4;91(7):577-84. doi: 10.1161/01.res.0000036901.58329.d7. Circ Res. 2002. PMID: 12364385

9

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.

Lamfers ML, Grimbergen JM, Aalders MC, Havenga MJ, de Vries MR, Huisman LG, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: quax ph. Circ Res. 2002 Nov 15;91(10):945-52. doi: 10.1161/01.res.0000041418.51906.57. Circ Res. 2002. PMID: 12433840

10

Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.

Lamfers ML, Aalders MC, Grimbergen JM, de Vries MR, Kockx MM, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: quax ph. Vascul Pharmacol. 2002 Dec;39(6):293-301. doi: 10.1016/s1537-1891(03)00043-0. Vascul Pharmacol. 2002. PMID: 14567067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page